2666 — Genertec Universal Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$8.87bn
- HK$60.51bn
- CNY13.65bn
- 34
- 94
- 70
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | PRESS | PRESS |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2,212 | 2,365 | 2,692 | 2,703 | 2,866 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 2,080 | 2,048 | 2,205 | 2,652 | 2,666 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -6,256 | -5,655 | -6,617 | -3,765 | -1,047 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1,824 | -972 | -1,401 | 2,032 | 4,994 |
Capital Expenditures | -208 | -401 | -385 | -618 | -897 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 121 | 105 | -279 | 496 | -162 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -87.4 | -297 | -665 | -121 | -1,059 |
Financing Cash Flow Items | -1,645 | -2,059 | -2,115 | -1,809 | -3,543 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3,022 | -34.6 | 2,392 | -1,576 | -3,794 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,212 | -1,349 | 306 | 309 | 144 |